Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,220.00    -56.00 (-4.39%)
Bid:
1,216.00
Ask:
1,226.00
Spread: 10.00 (0.822%)
Market Cap: £559.08m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Holding(s) in Company

19 Oct 2007 11:13

Cohort PLC19 October 2007 For filings with the FSA include the annexFor filings with issuer exclude the annex TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: COHORT PLC 2. Reason for notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: (X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to notification obligation: INVESCO PLC 4. Full name of shareholder(s) (if different from 3) : 5. Date of transaction (and date on which the threshold is crossed or reached if different): 10 OCTOBER 2007 6. Date on which issuer notified: 12 OCTOBER 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified Details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible use the Triggering transaction ISIN CODE Number of shares Number of voting Rights ORDINARY 10P SHARESGB00BOYD2B94 1,120,667 1,120,667 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible use ISIN CODE Direct Indirect Direct Indirect 1,640,667 1,640,667 5.56% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration date Exercise/conversion No. of voting % of voting financial period/date rights that may rights instrument be acquired (if the instrument exercised/ converted) Total (A+B)Number of voting rights % of voting rights 1,640,667 5.56% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: JP MORGAN CHASE - 495,050VIDACOS NOMINEES - 1,145,617 Proxy Voting: 10. Name of proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: ROSALIND MCDONALD 15. Contact telephone number: 01491 417404 For notes on how to complete form TR-1 please see the FSA website. Note: Annex should only be submitted to the FSA not the issuer This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.